欧洲GPA/MPA死亡率趋势:十年死亡登记数据的启示
该研究利用Eurostat 2011-2021年数据,分析29个欧洲国家以GPA或MPA为根本死因的死亡登记。结果显示GPA/MPA死亡率总体稳定,但死亡年龄中位数从70-74岁升至75-79岁;国家间差异显著,丹麦标化死亡率最高(31.03/千万),罗马尼亚最低(0.77/千万);GPA存在纬度梯度,斯堪的纳维亚最高,MPA无此梯度。
要点
- 2011-2021年欧洲GPA/MPA死亡率总体稳定,但死亡年龄中位数从70-74岁升至75-79岁。
- 丹麦标化死亡率最高(31.03/千万),罗马尼亚最低(0.77/千万),国家间差异显著。
- GPA标化死亡率存在纬度梯度,斯堪的纳维亚最高;MPA无此梯度。
核心结论
- 尽管疾病管理取得重大进展,过去十年GPA和MPA导致的死亡仍保持稳定,提示仍需改进治疗。
研究设计与样本
- 利用Eurostat公开数据,分析2011-2021年29个欧洲国家以GPA或MPA为根本死因的死亡登记,计算粗死亡率与标化死亡率(SMR),用线性回归分析时间趋势。
主要发现
- 2011-2021年GPA/MPA死亡率稳定,死亡年龄中位数从70-74岁升至75-79岁。
- 丹麦SMR最高(31.03/千万),罗马尼亚最低(0.77/千万)。
- 80岁以上成人死亡率更高,男性死亡多于女性。
- GPA的SMR存在纬度梯度,斯堪的纳维亚最高;MPA无纬度梯度。
关键数值与推荐
- GPA/MPA死亡率稳定,死亡年龄中位数从70-74岁升至75-79岁。
- 丹麦SMR 31.03/千万,罗马尼亚SMR 0.77/千万。
- 80岁以上成人死亡率更高,男性死亡多于女性。
- GPA的SMR存在纬度梯度,斯堪的纳维亚最高;MPA无。
临床怎么用
- 关注GPA/MPA死亡年龄上升趋势,对高龄患者加强管理。
- 注意国家间死亡率差异,尤其是丹麦等高SMR地区。
- GPA死亡存在纬度梯度,斯堪的纳维亚地区需关注。
局限性
- 基于死亡登记数据,可能存在编码错误或漏报。
- 仅分析根本死因,未考虑其他 contributing 因素。
- 未提供患者层面临床信息,无法分析治疗影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To examine contemporary trends in mortality due to granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in Europe. METHODS: We utilised publicly available data from Eurostat on deaths recorded with GPA or MPA as the underlying cause of death for the period 2011-2021. Crude and standardised mortality rates (SMRs) were calculated for each country and linear regression used to determine changes in mortality rates over time. Crude mortality rate was also stratified by age and sex. To investigate the association between geography and mortality rate, the SMR for each country was displayed on a choropleth map and plotted against the country's latitude. RESULTS: Our analysis of 29 European countries showed a stable mortality rate due to GPA and MPA between 2011-2021, but rising age at death (median age-band 70-74 at the start and 75-79 at the end of the study period). There were differences between countries with the highest mortality rate in Denmark (SMR 31.03 per 10 million) and the lowest in Romania (SMR 0.77 per 10 million). Mortality rates were higher in adults aged over 80 years and there were more deaths in men compared with women. A latitudinal gradient in SMR was seen in GPA but not MPA, with the highest mortality rates in Scandinavia. CONCLUSION: Despite major advances in disease management, our results show that deaths due to GPA and MPA were stable over the last decade, indicating an ongoing need to improve the treatment of these diseases.
引用
- Biddle K, Taylor A, Trimble TJ, et al. Trends in mortality due to GPA/MPA across Europe: insights from a decade of death registrations. Rheumatology (Oxford). 2026. PMID: 41719200. doi:10.1093/rheumatology/keag100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。